HIV and the kidney

[1]  K. Honda,et al.  Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. , 2009, Blood.

[2]  L. Kuller,et al.  Interruption of antiretroviral therapy is associated with increased plasma cystatin C , 2009, AIDS.

[3]  L. Szczech,et al.  Kidney disease in patients with HIV infection and AIDS. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Scott D. Cohen,et al.  Immune complex renal disease and human immunodeficiency virus infection. , 2008, Seminars in nephrology.

[5]  D. Fine,et al.  Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient. , 2008, Seminars in nephrology.

[6]  J. Gallant,et al.  The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients , 2008, AIDS.

[7]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[8]  Lewis H Kuller,et al.  Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection , 2008, PLoS medicine.

[9]  P. Peters,et al.  Antiretroviral therapy improves renal function among HIV-infected Ugandans. , 2008, Kidney international.

[10]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[11]  Judith N. Mandl,et al.  Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections , 2008, Nature Medicine.

[12]  B. Chi,et al.  Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia , 2008, AIDS.

[13]  E. Daugas,et al.  Acute Kidney Disease Due to Immune Reconstitution Inflammatory Syndrome in an HIV-Infected Patient With Tuberculosis , 2008, Journal of the International Association of Physicians in AIDS Care.

[14]  Richard D Moore,et al.  Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. , 2008, The Journal of infectious diseases.

[15]  I. Williams,et al.  Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  R. Iyengar,et al.  HIV-1 Nef Disrupts the Podocyte Actin Cytoskeleton by Interacting with Diaphanous Interacting Protein* , 2008, Journal of Biological Chemistry.

[17]  L. Szczech,et al.  Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease , 2008, AIDS.

[18]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[19]  K. Khan,et al.  Is HIV infection a TNF receptor signalling-driven disease? , 2008, Trends in immunology.

[20]  Richard D Moore,et al.  End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 , 2007, AIDS.

[21]  S. Sidney,et al.  Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. , 2007, Archives of internal medicine.

[22]  A. Heredia,et al.  Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment , 2007, AIDS.

[23]  S. Tezenas du Montcel,et al.  Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  F. Post,et al.  HIV-1 infection and the kidney: an evolving challenge in HIV medicine. , 2007, Mayo Clinic proceedings.

[25]  A. Gharavi,et al.  Genetic susceptibility, HIV infection, and the kidney. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[26]  A. Mocroft,et al.  Chronic renal failure among HIV-1-infected patients , 2007, AIDS.

[27]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[28]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[29]  P. Ramdial,et al.  A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. , 2006, Kidney international.

[30]  P. Klotman,et al.  HIV-1 Infection Initiates an Inflammatory Cascade in Human Renal Tubular Epithelial Cells , 2006, Journal of acquired immune deficiency syndromes.

[31]  Scott Martinka,et al.  Persistent NF-κB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy , 2006 .

[32]  P. Klotman,et al.  Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality , 2006, AIDS.

[33]  V. D’Agati,et al.  HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN , 2005, AIDS.

[34]  T. Matsusaka,et al.  Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. , 2005, Kidney international.

[35]  V. D’Agati,et al.  NF-κB regulates Fas-mediated apoptosis in HIV-associated nephropathy , 2005 .

[36]  K. Tashima,et al.  Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  L. Szczech,et al.  Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. , 2005, Kidney international.

[38]  B. Gazzard,et al.  Renal Dysfunction With Tenofovir Disoproxil Fumarate-Containing Highly Active Antiretroviral Therapy Regimens Is Not Observed More Frequently: A Cohort and Case-Control Study , 2004, Journal of acquired immune deficiency syndromes.

[39]  G. Mcgwin,et al.  Factors associated with chronic renal failure in HIV-infected ambulatory patients , 2004, AIDS.

[40]  Mardge H. Cohen,et al.  Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  L. Svetkey,et al.  The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. , 2004, Kidney international.

[42]  R. Iyengar,et al.  Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. , 2004, The Journal of clinical investigation.

[43]  Richard D Moore,et al.  Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study , 2004, AIDS.

[44]  J. He,et al.  Critical role for Nef in HIV-1-induced podocyte dedifferentiation. , 2003, Kidney international.

[45]  P. Kimmel,et al.  The HIV-associated renal diseases: current insight into pathogenesis and treatment. , 2003, Kidney international.

[46]  D. Droz,et al.  Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  V. D’Agati,et al.  Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy , 2002, Nature Medicine.

[49]  S. Holmberg,et al.  Use of Highly Active Antiretroviral Therapy in HIV‐Infected Women: Impact of HIV Specialist Care , 2002, Journal of acquired immune deficiency syndromes.

[50]  M. Saleem,et al.  Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. , 2001, The Journal of clinical investigation.

[51]  V. D’Agati,et al.  J Am Soc Nephrol 11: 2079–2087, 2000 Renal Epithelium Is a Previously Unrecognized Site of HIV-1 Infection , 2022 .

[52]  B. Kasiske,et al.  Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes. , 1998, Kidney international.

[53]  S. Dikman,et al.  Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. , 1997, The Journal of clinical investigation.

[54]  P. Ruiz,et al.  Immunopathological characteristics of in situ T-cell subpopulations in human immunodeficiency virus-associated nephropathy. , 1995, Human pathology.

[55]  P. Kimmel,et al.  HIV-associated immune-mediated renal disease. , 1993, Kidney international.

[56]  P. Shapshak,et al.  Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[57]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .